Medipharm Labs Corp T.LABS

RE:Big implications for MPL

[okgonow]

alleyesonme wrote: Remember this...On the global scale, there are certainly considerations that will need to be made as the change relates to the single convention on psychotropic substances but there’s also potential opportunity for international cannabis manufacturers in the United States. As was just referenced one of the areas that state cannabis production may struggle is upgrading their production environments to a GMP standard. As it stands presently there is only one public cannabis company that has completed FDA inspections and has delivered approved research material to American researchers. This company is MediPharm Labs based in Ontario, Canada.https://businessofcannabis.com/us-reschedule-cannabis-drug-policy-opportunities-industry/

"

This GMP certification from Brazil strengthens MediPharm's position as one of the most pharmaceutically focused medical cannabis companies in the world. The certification joins our long list of global regulatory achievements, including US FDA, Australian TGA, European Union pharmaceutical GMP and Canadian pharmaceutical GMP authorizations. Whether it is the production for cannabis-based drug research, international cannabis medical programs or future marketable cannabis drugs, MediPharm has invested in and executed on the development of global pharmaceutical and medical channels. We believe this positions us well for future growth with a suite of capabilities, certifications and approvals unmatched globally," commented David Pidduck, MediPharm Labs CEO.